Evidence map›Paper›PMID 36923413›Full record

ArticleFrontiers in immunology2023

B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease.

Daniela Giordano, Runa Kuley, Kevin E Draves, Keith B Elkon, Natalia V Giltiay, Edward A Clark

Open access · goldFull text read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Role of Novel Immunomodulators in the Treatment of Autoimmune Hepatitis.Journal of clinical and translational hepatology · 2025
    Review
  11. Review
  12. Primary immunodeficiency as a cause of immune-mediated kidney diseases.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Review
  13. Article
  14. Neutrophil extracellular traps in homeostasis and disease.Signal transduction and targeted therapy · 2024
    Review
  15. Review
  16. Review
  17. Article
  18. Inflammatory CD11bPathogens (Basel, Switzerland) · 2024
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Daniela GiordanoDepartment of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
Runa KuleyDepartment of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
Kevin E DravesDepartment of Microbiology, University of Washington, Seattle, WA, United States.
Keith B ElkonDepartment of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
Natalia V GiltiayDepartment of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
Edward A ClarkDepartment of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, United States.
University of Washington · US

Funding

Role of B cell activating factor (BAFF) in B cell responses and autoimmunityR01AI044257 · NIAID · UNIVERSITY OF WASHINGTON · PI GILTIAY, NATALIA V · 1999 to 2020
$3.7M
NIAID NIH HHS R01 AI044257
6 · The paper itself

Abstract

Purpose and methods: B cell-activating factor (BAFF) contributes to the pathogenesis of autoimmune diseases including systemic lupus erythematosus (SLE). Although several anti-BAFF Abs and derivatives have been developed for the treatment of SLE, the specific sources of BAFF that sustain autoantibody (auto-Ab) producing cells have not been definitively identified. Using BAFF-RFP reporter mice, we identified major changes in BAFF-producing cells in two mouse spontaneous lupus models ( Results: First, we confirmed that similar to their wildtype Conclusions: Our findings underscore the importance of considering the relative roles of specific myeloid BAFF sources and B cell niches when developing treatments for SLE and other BAFF-associated autoimmune diseases.

Indexed as

Autoimmune DiseasesLupus Erythematosus, SystemicAnimalsAutoantibodiesB-Cell Activating FactorDendritic CellsDisease Models, AnimalInterleukin-4MiceMonocytesNeutrophilsTerpenesToll-Like Receptor 7AutoantibodiesB-Cell Activating FactorInterleukin-4pristaneTerpenesTnfsf13b protein, mouseToll-Like Receptor 7autoantibodiesautoimmunityBAFFB cellsdendritic cellsmonocytesneutrophilsSLE

Identifiers

PMID36923413
PMCPMC10009188
OpenAlexW4322503128

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read38
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.